Mark C. Rogers
Founder at Gibson Oncology LLC
Profile
Mark C.
Rogers is the founder of Gibson Oncology LLC.
Prior to this, he served as Chairman at Correvio Pharma Corp., Bradmer Pharmaceuticals, Inc., and Reagan-udall Foundation.
He holds an undergraduate degree from The Trustees of Columbia University in The City of New York, a doctorate from SUNY Upstate Medical University, and an MBA from The Wharton School of the University of Pennsylvania.
Mark C. Rogers active positions
| Companies | Position | Start |
|---|---|---|
Gibson Oncology LLC
 Gibson Oncology LLC BiotechnologyHealth Technology Gibson Oncology LLC composes proven academic researchers and bio tech entrepreneurs. The firm also develops novel oncology drugs to treat resistant cancers with a focus on children. The company was founded by Mark C. Rogers, Theodore C, Solomon, Cliff T. Solomon and Elizabeth L. Rogers and is headquartered in Miami, FL. | Founder | - |
Former positions of Mark C. Rogers
| Companies | Position | End |
|---|---|---|
Bradmer Pharmaceuticals, Inc.
 Bradmer Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Bradmer Pharmaceuticals, Inc. engaged in the development and commercialization of cancer therapies. The company was founded on June 16, 2005 and wass headquartered in Toronto, Canada. | Chairman | 2010-03-25 |
| CORREVIO PHARMA CORP. | Chairman | 2007-03-15 |
| Reagan-udall Foundation | Chairman | - |
Training of Mark C. Rogers
| The Trustees of Columbia University in The City of New York | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
| SUNY Upstate Medical University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Correvio Pharma Corp.
 Correvio Pharma Corp. Pharmaceuticals: MajorHealth Technology Correvio Pharma Corp. operates as a pharmaceutical company, which engages in the provision of development and commercialization of medical products. It operates through the Europe and Rest of the World geographical segments. The firm focuses on cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease. It offers the Brinavess and Aggrastat products to customers such as physicians, patients and healthcare systems. The company was founded in 1986 and is headquartered in Vancouver, Canada. | Health Technology |
Bradmer Pharmaceuticals, Inc.
Bradmer Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Bradmer Pharmaceuticals, Inc. engaged in the development and commercialization of cancer therapies. The company was founded on June 16, 2005 and wass headquartered in Toronto, Canada. | Commercial Services |
| Reagan-udall Foundation | |
Gibson Oncology LLC
Gibson Oncology LLC BiotechnologyHealth Technology Gibson Oncology LLC composes proven academic researchers and bio tech entrepreneurs. The firm also develops novel oncology drugs to treat resistant cancers with a focus on children. The company was founded by Mark C. Rogers, Theodore C, Solomon, Cliff T. Solomon and Elizabeth L. Rogers and is headquartered in Miami, FL. | Health Technology |
- Stock Market
- Insiders
- Mark C. Rogers
